The optimal dose of ribavirin for chronic hepatitis C: From literature evidence to clinical practice: The optimal dose of ribavirin for chronic hepatitis C

Approximately 170 million people worldwide are chronically infected by hepatitis C virus (HCV), which can result in progressive hepatic injury and fibrosis, culminating in cirrhosis and end-stage liver disease. The benchmark therapy for untreated HCV patients is a combination of pegylated interferon...

Descripción completa

Detalles Bibliográficos
Autores principales: Abenavoli, Ludovico, Mazza, Marta, Almasio, Piero L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Kowsar 2011
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3206692/
https://www.ncbi.nlm.nih.gov/pubmed/22087150

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3206692/
https://www.ncbi.nlm.nih.gov/pubmed/22087150

Ejemplares similares